| Walmart Pharmacy 10-3164 | |
| 205 N Main St, Bentonville, Arkansas 72712 | |
| (479) 268-9243 |
| Name | Walmart Pharmacy 10-3164 |
|---|---|
| Organization Name | Walmart Inc |
| Location | 205 N Main St, Bentonville, Arkansas 72712 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (479) 268-9243 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Results from a new sub-analysis of the JUPITER study show that patients who attained a dual treatment target of LDL-C <70mg/dL and high-sensitivity C-reactive protein (hsCRP) <2mg/L with CRESTOR (rosuvastatin) 20mg achieved a greater reduction in cardiovascular events compared to placebo than those who did not (65% vs 36%, p=0.033) among men and women with low to normal cholesterol levels and elevated hsCRP.
New research with funding from UK charity Action on Hearing Loss has led to the discovery of a new biological mechanism involved in the progressive loss of hearing which could lead to new approaches to treating this common form of hearing loss.
The Cancer Prevention and Research Institute of Texas (CPRIT) released five cancer research requests for applications (RFA) just three months after receiving its first funding. In May, 2009, the 81st Legislature appropriated $450 million dollars in bond proceeds for the next two years for CPRIT to fund cancer research and prevention grants that will expedite innovation in cancer treatment and expand cancer prevention services in the state.
In a study published in the current issue of The American Journal of Medicine, researchers from the State University of Campinas, São Paulo, Brazil; Catholic University, Rome, Italy; and the University of Pisa, Italy, found that the degree of improvement depended on the surgical technique used, comparing biliopancreatic diversion to gastric bypass.
› Verified 3 days ago
| NPI Number | 1134995061 |
| Organization Name | WAL-MAT STORES TEXAS, LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 205 N Main St, Bentonville, AR 72712 |
| Phone Number | 479-268-9243 |
News Archive
Results from a new sub-analysis of the JUPITER study show that patients who attained a dual treatment target of LDL-C <70mg/dL and high-sensitivity C-reactive protein (hsCRP) <2mg/L with CRESTOR (rosuvastatin) 20mg achieved a greater reduction in cardiovascular events compared to placebo than those who did not (65% vs 36%, p=0.033) among men and women with low to normal cholesterol levels and elevated hsCRP.
New research with funding from UK charity Action on Hearing Loss has led to the discovery of a new biological mechanism involved in the progressive loss of hearing which could lead to new approaches to treating this common form of hearing loss.
The Cancer Prevention and Research Institute of Texas (CPRIT) released five cancer research requests for applications (RFA) just three months after receiving its first funding. In May, 2009, the 81st Legislature appropriated $450 million dollars in bond proceeds for the next two years for CPRIT to fund cancer research and prevention grants that will expedite innovation in cancer treatment and expand cancer prevention services in the state.
In a study published in the current issue of The American Journal of Medicine, researchers from the State University of Campinas, São Paulo, Brazil; Catholic University, Rome, Italy; and the University of Pisa, Italy, found that the degree of improvement depended on the surgical technique used, comparing biliopancreatic diversion to gastric bypass.
› Verified 3 days ago
| NPI Number | 1710355243 |
| Organization Name | WALMART INC. |
| Doing Business As | WALMART PHARMACY 10-3164 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 205 N Main St, Bentonville, AR 72712 |
| Phone Number | 479-268-9243 |
News Archive
Results from a new sub-analysis of the JUPITER study show that patients who attained a dual treatment target of LDL-C <70mg/dL and high-sensitivity C-reactive protein (hsCRP) <2mg/L with CRESTOR (rosuvastatin) 20mg achieved a greater reduction in cardiovascular events compared to placebo than those who did not (65% vs 36%, p=0.033) among men and women with low to normal cholesterol levels and elevated hsCRP.
New research with funding from UK charity Action on Hearing Loss has led to the discovery of a new biological mechanism involved in the progressive loss of hearing which could lead to new approaches to treating this common form of hearing loss.
The Cancer Prevention and Research Institute of Texas (CPRIT) released five cancer research requests for applications (RFA) just three months after receiving its first funding. In May, 2009, the 81st Legislature appropriated $450 million dollars in bond proceeds for the next two years for CPRIT to fund cancer research and prevention grants that will expedite innovation in cancer treatment and expand cancer prevention services in the state.
In a study published in the current issue of The American Journal of Medicine, researchers from the State University of Campinas, São Paulo, Brazil; Catholic University, Rome, Italy; and the University of Pisa, Italy, found that the degree of improvement depended on the surgical technique used, comparing biliopancreatic diversion to gastric bypass.
› Verified 3 days ago
| NPI Number | 1730955659 |
| Organization Name | WAL-MART STORES EAST, LP |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 205 N Main St, Bentonville, AR 72712 |
| Phone Number | 479-268-9243 |
News Archive
Results from a new sub-analysis of the JUPITER study show that patients who attained a dual treatment target of LDL-C <70mg/dL and high-sensitivity C-reactive protein (hsCRP) <2mg/L with CRESTOR (rosuvastatin) 20mg achieved a greater reduction in cardiovascular events compared to placebo than those who did not (65% vs 36%, p=0.033) among men and women with low to normal cholesterol levels and elevated hsCRP.
New research with funding from UK charity Action on Hearing Loss has led to the discovery of a new biological mechanism involved in the progressive loss of hearing which could lead to new approaches to treating this common form of hearing loss.
The Cancer Prevention and Research Institute of Texas (CPRIT) released five cancer research requests for applications (RFA) just three months after receiving its first funding. In May, 2009, the 81st Legislature appropriated $450 million dollars in bond proceeds for the next two years for CPRIT to fund cancer research and prevention grants that will expedite innovation in cancer treatment and expand cancer prevention services in the state.
In a study published in the current issue of The American Journal of Medicine, researchers from the State University of Campinas, São Paulo, Brazil; Catholic University, Rome, Italy; and the University of Pisa, Italy, found that the degree of improvement depended on the surgical technique used, comparing biliopancreatic diversion to gastric bypass.
› Verified 3 days ago
| NPI Number | 1841066768 |
| Organization Name | WAL-MART STORES TEXAS, LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 205 N Main St, Bentonville, AR 72712 |
| Phone Number | 479-268-9243 |
News Archive
Results from a new sub-analysis of the JUPITER study show that patients who attained a dual treatment target of LDL-C <70mg/dL and high-sensitivity C-reactive protein (hsCRP) <2mg/L with CRESTOR (rosuvastatin) 20mg achieved a greater reduction in cardiovascular events compared to placebo than those who did not (65% vs 36%, p=0.033) among men and women with low to normal cholesterol levels and elevated hsCRP.
New research with funding from UK charity Action on Hearing Loss has led to the discovery of a new biological mechanism involved in the progressive loss of hearing which could lead to new approaches to treating this common form of hearing loss.
The Cancer Prevention and Research Institute of Texas (CPRIT) released five cancer research requests for applications (RFA) just three months after receiving its first funding. In May, 2009, the 81st Legislature appropriated $450 million dollars in bond proceeds for the next two years for CPRIT to fund cancer research and prevention grants that will expedite innovation in cancer treatment and expand cancer prevention services in the state.
In a study published in the current issue of The American Journal of Medicine, researchers from the State University of Campinas, São Paulo, Brazil; Catholic University, Rome, Italy; and the University of Pisa, Italy, found that the degree of improvement depended on the surgical technique used, comparing biliopancreatic diversion to gastric bypass.
› Verified 3 days ago
News Archive
Results from a new sub-analysis of the JUPITER study show that patients who attained a dual treatment target of LDL-C <70mg/dL and high-sensitivity C-reactive protein (hsCRP) <2mg/L with CRESTOR (rosuvastatin) 20mg achieved a greater reduction in cardiovascular events compared to placebo than those who did not (65% vs 36%, p=0.033) among men and women with low to normal cholesterol levels and elevated hsCRP.
New research with funding from UK charity Action on Hearing Loss has led to the discovery of a new biological mechanism involved in the progressive loss of hearing which could lead to new approaches to treating this common form of hearing loss.
The Cancer Prevention and Research Institute of Texas (CPRIT) released five cancer research requests for applications (RFA) just three months after receiving its first funding. In May, 2009, the 81st Legislature appropriated $450 million dollars in bond proceeds for the next two years for CPRIT to fund cancer research and prevention grants that will expedite innovation in cancer treatment and expand cancer prevention services in the state.
In a study published in the current issue of The American Journal of Medicine, researchers from the State University of Campinas, São Paulo, Brazil; Catholic University, Rome, Italy; and the University of Pisa, Italy, found that the degree of improvement depended on the surgical technique used, comparing biliopancreatic diversion to gastric bypass.
› Verified 3 days ago
Amerita Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2709 Southeast Otis Corley Drive, Bentonville, Arkansas 72712 Phone: (844) 217-2252 | |
Decker Eye Care Type: Medicare Supplier Location: 813 W Central Ave, Bentonville, Arkansas 72712 Phone: (479) 855-0009 | |
Pam's Pllc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 907 Se Village Loop, Bentonville, Arkansas 72712 Phone: (479) 287-4748 | |
Sams Pharmacy 10-4969 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3500 Southeast Club Blvd, Bentonville, Arkansas 72712 Phone: (479) 621-0283 | |
Aerocare Home Medical Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1805 Sw Regional Airport Blvd, Bentonville, Arkansas 72713 Phone: (479) 464-4969 |